TSC2 and tuberous sclerosis: Finally, although limited reports of gastrointestinal manifestations of TSC are in the literature, we found no evidence of loss TSC2 in contributing to the pathogenesis of the duodenal adenocarcinoma (Santos et al. 2015; Reis et al. 2020).